Digital ERAS platform to shorten hospital stay after coronary artery bypass grafting
Official title: Estudo Randomizado de Cluster Escalonado Para Avaliar o Impacto de Uma Plataforma tecnológica Baseada no ERAS (Enhanced Recovery After Surgery) no Tempo de permanência após Cirurgia de revascularização miocárdica: Projeto Tempos Certos - REPLICCAR III
Run by University of Sao Paulo General Hospital · NCT06786819 · Data updated 2026-11-12
This project tests a digital platform based on ERAS to see if it shortens hospital stays for adults having primary isolated CABG.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 480 (estimated) |
| Sponsor | University of Sao Paulo General Hospital Academic / other |
| Locations | 2 sites (São Paulo, São Paulo and 1 other locations) |
| Status | Recruiting |
| Started | March 10, 2025 |
| Main results expected | August 30, 2026 |
| Study ends | September 1, 2026 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT06786819 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older scheduled for primary isolated CABG who own and can use a smartphone with internet access and meet basic medical/laboratory criteria (for example, Hb ≥12 g/dL, creatinine clearance ≥30 mL/min, A1c ≤8%).
✕Probably not a fit
Patients needing additional cardiac procedures, with preoperative atrial fibrillation or anticoagulation, very poor kidney function, severe anemia, STS score >4%, illicit drug use, or those unable to use a smartphone are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional project implements an Enhanced Recovery After Surgery (ERAS) pathway supported by a digital platform for adults undergoing primary isolated coronary artery bypass grafting. Participants who own and can use a smartphone will receive perioperative care guidance, monitoring, and communications through the platform while clinical outcomes are tracked. The main outcome is hospital length of stay, with safety and adherence monitored using standard preoperative and postoperative criteria. The trial is conducted at InCor (Hospital das Clínicas, FMUSP) within a framework informed by regional cardiovascular registry data.
Why it matters
Potential benefit: If successful, the platform could help patients leave the hospital sooner, recover faster, and potentially experience fewer complications and lower costs.
How similar studies have gone: Similar ERAS pathways and some digital perioperative programs have been associated with shorter stays and faster recovery in observational studies and limited trials, but combining ERAS with a dedicated digital platform for CABG is still relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults over 18 years old * Indication for primary isolated CABG (elective or urgent status) * Own a personal cell phone * Have internet access * Knowledgeable in using the device * Full understanding and agreement regarding the informed consent form (ICF) Exclusion Criteria: * Indication for associated surgery * Glycosylated hemoglobin level greater than 8% * Creatinine clearance less than 30 mL/min * Pre-operative atrial fibrillation or use of pre-operative anticoagulation * Hemoglobin less than 12 g/dL * Users of illicit drugs * STS score greater than 4% * Physical or mental disabilities that prevent adherence to the protocol * Refusal by the patient or family member
Where it's running
-
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
São Paulo, São Paulo, Brazil Recruiting -
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Omar A V Mejia, MD, PhD — InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
- Study coordinator: Omar A V Mejia, MD, PhD
- Email: omar.mejia@incor.usp.br
- Phone: +551126615014
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of Fast-Track Anesthesia on Postoperative Delirium After Cardiac Surgery
This observational study tests whether fast-track anesthesia, compared with conventional care, is linked to lower rates of delirium after elective cardiac surgery in adults.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Preoperative functional optimization for adults undergoing major cardiac or abdominal surgery
This study tests a four‑week prehabilitation program to improve fitness before elective major cardiac or abdominal surgery.
-
Digitally Enabled Districts 2.0: Aimed at Improving Maternal and Neonatal Care in Garut
A stepped-wedge trial tests whether an integrated digital health ecosystem helps 45 local clinics in Garut improve the completeness and timeliness of maternal and neonatal care.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.